Physician profile
William Sam Shields
NPI 1538165303
$1,765.55
in general payments reported to CMS, 2019-2025
12 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $107 · 2021: $266 · 2022: $366 · 2023: $513 · 2024: $178 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552 · Entertainment: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $551.95 |
| Entertainment | $241.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $413.75 | 2019-2025 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $282.02 | 2022-2024 | Infuse |
| Optos, INC. | $257.61 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $222.02 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $218.55 | 2019-2025 | Precision 1, Precision7, Total30 |
| Novartis Pharmaceuticals Corporation | $113.17 | 2022 | |
| Sun Pharmaceutical Industries INC. | $81.99 | 2022 | |
| Abb Con-Cise Optical Group LLC | $64.00 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.66 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $34.83 | 2023 | Lipiflow System Activator (Disposable) |
| Maculogix, INC. | $19.55 | 2020 | |
| Rxsight INC | $18.40 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.